Page 45 - GHES-2-2
P. 45

Global Health Econ Sustain                                                   MDR-TB and the road ahead



               [Last accessed on 2024 Jan 20].                    https://doi.org/10.1371/journal.pone.0270003
            World Health Organization. (2021). WHO Global Lists of High   Yadav, R.N., Verma, A.K., & Kaushik, G., (2022). Laboratory
               Burden Countries for Tuberculosis (TB), TB/HIV and   cost analysis of conventional and newer molecular tests for
               Multidrug/Rifampicin-Resistant TB (MDR/RR-TB), 2021-  diagnosis of presumptive multidrug-resistant tuberculosis
               2025: Background Document. Available from: https://www.  patients. Journal of Global Infectious Diseases, 14(3):93-98.
               who.int/news/item/17-06-2021-who-releases-new-global-
               lists-of-high-burden-countries-for-tb-hiv-associated-tb-     https://doi.org/10.4103/jgid.jgid_309_21
               and-drug-resistant-tb [Last accessd on 2024 Jan 24].  Yang, T., Chen, T., Che, Y., Chen, Q., & Bo, D. (2020). Factors
            World Health Organization. (2022). WHO Consolidated   associated with catastrophic total costs due to tuberculosis
               Guidelines  on  Tuberculosis:  Module  4:  Treatment-drug   under a designated hospital service model: A cross-sectional
               Resistant Tuberculosis Treatment, 2022 Update. Available   study in China. BMC Public Health, 20(1):1009.
               from:  https://www.ncbi.nlm.nih.gov/books/NBK588557     https://doi.org/10.1186/s12889-020-09136-z
               [Last accessed on 2024 Jan 30].
                                                               Yu, M.C., Chiang, C.T., Lee, J.J., Chien, S.T., Lin, C.J., Lee, S.W.,
            World Health Organization. (2023). Global Tuberculosis   et al. (2018). Treatment outcomes of multidrug-resistant
               Report 2023. Available from: https://cdn.who.int/media/  tuberculosis in Taiwan: Tackling loss to follow-up. Clinical
               docs/default-source/hq-tuberculosis/global-tuberculosis-  Infectious Diseases, 67(2):202-210.
               report-2023/top-findings-and-messages-in-the-2023-
               report.pdf?sfvrsn=2d4dd1bd_18&download=true  [Last     https://doi.org/10.1093/cid/ciy066
               accessed on 2024 Jan 20].                       Zijenah,  L.S.  (2018).  The  World  Health Organization
            Xi, Y., Zhang, W., Qiao, R.J., & Tang, J. (2022). Risk factors for   Recommended TB Diagnostic Tools. Available from: https://
               multidrug-resistant tuberculosis: A  worldwide systematic   www.the/world/health/organization/recommended/tb/
               review and meta-analysis. PLoS One, 17(6):e0270003.  diagnostic/tools/intechopen [Last accessed on 2024 Feb 22].
















































            Volume 2 Issue 2 (2024)                         8                        https://doi.org/10.36922/ghes.2876
   40   41   42   43   44   45   46   47   48   49   50